Lindbrook Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | $3.06M | Buy |
6,308
+5,202
| +470% | +$2.52M | 0.28% | 53 |
|
2024
Q4 | $445K | Sell |
1,106
-28,526
| -96% | -$11.5M | 0.04% | 242 |
|
2024
Q3 | $13.8M | Buy |
29,632
+7,872
| +36% | +$3.66M | 1.22% | 13 |
|
2024
Q2 | $10.2M | Sell |
21,760
-8,428
| -28% | -$3.95M | 0.96% | 16 |
|
2024
Q1 | $12.6M | Buy |
30,188
+18,996
| +170% | +$7.94M | 1.18% | 14 |
|
2023
Q4 | $4.55M | Buy |
11,192
+5,161
| +86% | +$2.1M | 0.45% | 42 |
|
2023
Q3 | $2.1M | Sell |
6,031
-5,345
| -47% | -$1.86M | 0.23% | 65 |
|
2023
Q2 | $4M | Sell |
11,376
-20,406
| -64% | -$7.18M | 0.43% | 42 |
|
2023
Q1 | $10M | Sell |
31,782
-157
| -0.5% | -$49.5K | 1.17% | 11 |
|
2022
Q4 | $9.22M | Buy |
31,939
+24,198
| +313% | +$6.99M | 1.14% | 12 |
|
2022
Q3 | $2.24M | Buy |
7,741
+3,208
| +71% | +$929K | 0.38% | 31 |
|
2022
Q2 | $1.28M | Buy |
4,533
+1,762
| +64% | +$496K | 0.21% | 64 |
|
2022
Q1 | $723K | Buy |
2,771
+1,749
| +171% | +$456K | 0.11% | 115 |
|
2021
Q4 | $224K | Buy |
1,022
+536
| +110% | +$117K | 0.03% | 281 |
|
2021
Q3 | $88K | Sell |
486
-23
| -5% | -$4.17K | 0.02% | 292 |
|
2021
Q2 | $103K | Sell |
509
-14
| -3% | -$2.83K | 0.02% | 288 |
|
2021
Q1 | $112K | Buy |
523
+11
| +2% | +$2.36K | 0.03% | 250 |
|
2020
Q4 | $121K | Sell |
512
-46
| -8% | -$10.9K | 0.03% | 208 |
|
2020
Q3 | $152K | Buy |
558
+64
| +13% | +$17.4K | 0.04% | 153 |
|
2020
Q2 | $143K | Sell |
494
-8
| -2% | -$2.32K | 0.04% | 158 |
|
2020
Q1 | $119K | Sell |
502
-164
| -25% | -$38.9K | 0.05% | 166 |
|
2019
Q4 | $146K | Sell |
666
-65
| -9% | -$14.2K | 0.05% | 189 |
|
2019
Q3 | $124K | Sell |
731
-15
| -2% | -$2.54K | 0.05% | 200 |
|
2019
Q2 | $136K | Buy |
746
+17
| +2% | +$3.1K | 0.05% | 184 |
|
2019
Q1 | $134K | Hold |
729
| – | – | 0.05% | 180 |
|
2018
Q4 | $120K | Buy |
+729
| New | +$120K | 0.06% | 169 |
|